Validity of Medication Adherence Self-Reports in Adults With Type 2 Diabetes

Diabetes Care - Tập 36 Số 4 - Trang 831-837 - 2013
Jeffrey S. Gonzalez1,2, Havah E. Schneider2, Deborah J. Wexler3, Christina Psaros4, Linda M. Delahanty3, Enrico Cagliero3, Steven A. Safren4
1Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York
2Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, New York
3Diabetes Center, Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, and
4Behavioral Medicine, Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, Boston, Massachusetts.

Tóm tắt

OBJECTIVE To assess the validity of self-report measures of diabetes medication adherence and evaluate the effect of depression on the validity of these reports. RESEARCH DESIGN AND METHODS Adults with type 2 diabetes, treated with oral medications, completed a set of medication adherence self-reports that varied response scales and time frames, were administered structured clinical interviews for depression, and provided blood samples for HbA1c as part of a screening for an intervention study. A subsample of participants with HbA1c ≥7.0% and clinically significant depression received Medication Event Monitoring System (MEMS) bottle caps to record adherence. Analyses examined relationships between adherence measures and HbA1c and, in the subsample, MEMS. Moderated linear regression evaluated whether depression severity modified relationships with HbA1c. RESULTS Participant (n = 170, 57% men, 81% white, mean HbA1c 8.3% [SD, 1.7]) adherence self-reports were significantly (r = −0.18 to −0.28; P < 0.03) associated with lower HbA1c. In the subsample (n = 88), all self-reports were significantly (r = 0.35 to 0.55; P ≤ 0.001) associated with MEMS-measured adherence. Depression significantly moderated the relationship between three of six self-reports and HbA1c; at high levels of depression, associations with HbA1c became nonsignificant. CONCLUSIONS Results support the validity of easily administered self-reports for diabetes medication adherence. One-month, percentage-based ratings of adherence had the strongest associations with MEMS and HbA1c; those requiring the report of missed doses had weaker associations. One-week self-ratings and measures that require respondents to record the number of missed doses appear to be vulnerable to bias from depression severity.

Từ khóa


Tài liệu tham khảo

Ho, 2006, Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus, Arch Intern Med, 166, 1836, 10.1001/archinte.166.17.1836

Gonzalez, 2011, Methodological issues in the assessment of diabetes treatment adherence, Curr Diab Rep, 11, 472, 10.1007/s11892-011-0229-4

Toobert, 2000, The summary of diabetes self-care activities measure: results from 7 studies and a revised scale, Diabetes Care, 23, 943, 10.2337/diacare.23.7.943

Krapek, 2004, Medication adherence and associated hemoglobin A1c in type 2 diabetes, Ann Pharmacother, 38, 1357, 10.1345/aph.1D612

Hill-Briggs, 2005, Medication adherence and diabetes control in urban African Americans with type 2 diabetes, Health Psychol, 24, 349, 10.1037/0278-6133.24.4.349

Al-Qazaz, 2010, The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version, Diabetes Res Clin Pract, 90, 216, 10.1016/j.diabres.2010.08.012

Sakthong, 2009, Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes, Ann Pharmacother, 43, 950, 10.1345/aph.1L453

Wang, 2012, Validity and reliability of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Singapore, e338

Rhee, 2005, Patient adherence improves glycemic control, Diabetes Educ, 31, 240, 10.1177/0145721705274927

Tiv, 2012, Medication adherence in type 2 diabetes: the ENTRED study 2007, a French population-based study, PLoS ONE, 7, e32412, 10.1371/journal.pone.0032412

Cohen, 2010, Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c), Diabet Med, 27, 210, 10.1111/j.1464-5491.2009.02898.x

Lu, 2008, Optimal recall period and response task for self-reported HIV medication adherence, AIDS Behav, 12, 86, 10.1007/s10461-007-9261-4

Dunbar-Jacob, 2012, Accuracy of measures of medication adherence in a cholesterol-lowering regimen, West J Nurs Res, 34, 578, 10.1177/0193945912439251

Gonzalez, 2008, Depression and diabetes treatment nonadherence: a meta-analysis, Diabetes Care, 31, 2398, 10.2337/dc08-1341

Mathews, 1983, Mood and the self-reference bias in recall, Behav Res Ther, 21, 233, 10.1016/0005-7967(83)90204-8

Blaney, 1986, Affect and memory: a review, Psychol Bull, 99, 229, 10.1037/0033-2909.99.2.229

Ruiz-Caballero, 1994, Implicit and explicit memory bias in depressed and non depressed subjects, Cogn Emot, 8, 555, 10.1080/02699939408408959

Gonzalez, 2010, Cognitive behavioral therapy for adherence and depression (CBT-AD) in type 2 diabetes, J Cogn Psychotherapy, 24, 329, 10.1891/0889-8391.24.4.329

Montgomery, 1979, A new depression scale designed to be sensitive to change, Br J Psychiatry, 134, 382, 10.1192/bjp.134.4.382

Chesney, 2000, Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG), AIDS Care, 12, 255, 10.1080/09540120050042891

Toobert, 1994, Assessing diabetes self-management: the summary of diabetes self-care activities questionnaire, Handbook of Psychology and Diabetes, 351

Safren, 2009, A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals, Health Psychol, 28, 1, 10.1037/a0012715

Sheehan, 1998, The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J Clin Psychiatry, 59, 22

Silver, 2006, FORTRAN 77 program for comparing dependent correlations, Appl Psychol Meas, 30, 152, 10.1177/0146621605277132

Aiken, 1991, Multiple Regression: Testing and Interpreting Interactions

Hansen, 2009, Comparison of methods to assess medication adherence and classify nonadherence, Ann Pharmacother, 43, 413, 10.1345/aph.1L496

Hood, 2009, Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis, Pediatrics, 124, e1171, 10.1542/peds.2009-0207

Schectman, 2002, The association between diabetes metabolic control and drug adherence in an indigent population, Diabetes Care, 25, 1015, 10.2337/diacare.25.6.1015

Wilson, 2009, Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty?, Curr HIV/AIDS Rep, 6, 177, 10.1007/s11904-009-0024-x

Garfield, 2011, Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review, BMC Med Res Methodol, 11, 149, 10.1186/1471-2288-11-149

Kalichman, 2009, A simple single-item rating scale to measure medication adherence: further evidence for convergent validity, J Int Assoc Physicians AIDS Care (Chic), 8, 367, 10.1177/1545109709352884

Matt, 1992, Mood-congruent recall of affectively toned stimuli: a meta-analytic review, Clin Psychol Rev, 12, 227, 10.1016/0272-7358(92)90116-P

Ali, 2006, The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis, Diabet Med, 23, 1165, 10.1111/j.1464-5491.2006.01943.x

Simpson, 2006, A meta-analysis of the association between adherence to drug therapy and mortality, BMJ, 333, 15, 10.1136/bmj.38875.675486.55

Curtis, 2011, Placebo adherence, clinical outcomes, and mortality in the women’s health initiative randomized hormone therapy trials, Med Care, 49, 427, 10.1097/MLR.0b013e318207ed9e